Whitehaven Coal’s A$1bn Winchester South project clears major court hurdle but approvals remain outstanding
Read More Pharma Industry News Amgen submits BLA for Infliximab biosimilar ABP 710 to FDA Amgen Inc. has officially submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA)… bypharmanewsdailyDecember 18, 2018
